View all stories with this category.
Derek Lowe wonders whether peer-reviewed papers or patents are more reliable
Derek Lowe takes a look back over his 20 years as a medicinal chemist
Is the pharmaceutical industry churning out copycat versions of existing therapies? Derek Lowe dispels a few myths about 'me-too' drugs
Derek Lowe advises opening your mind during the screening cascade taken by potential drug targets, and remaining goal orientated at all times
Derek Lowe discusses the problem of leaning too heavily on favourite reactions
Derek Lowe wonders why some diseases are easier to drug than others
Derek Lowe considers what makes a good looking drug molecule - and how beauty is in the eye of the beholder
Derek Lowe wonders where we'd be without the formulation chemists
Derek Lowe wonders about pharmaceutical companies' motives for collaboration
Derek Lowe considers what we think we know about how drugs work once we've taken them
Derek Lowe considers the problems of addressing drug development out of sequence
Derek Lowe worries that mergers are upsetting the balance of the pharmaceutical ecosystem
How important is it to have the best equipped lab, wonders Derek Lowe
Derek Lowe discusses the age-old tradition of passing the buck
Derek Lowe ponders the likelihood of arriving where he started
Testing times for Derek Lowe
Derek Lowe seeks a cure for 'compound bloat'
Derek Lowe remembers leaving the ivory towers of academe to trade 'unusual and beautiful' for 'useful'
Derek Lowe is looking for a little more variety among his reactions
Derek Lowe says this is no time to be an 'ordinary' scientist
© Royal Society of Chemistry Registered charity number: 207890
Site powered by Webvision Cloud